Company Filing History:
6 out of 169 
2 out of 893 
2 out of 31 
Years Active: 1999-2024
Title: Eithan Galun: Innovator in Cancer Therapy
Introduction
Eithan Galun, based in Har Adar, Israel, has made significant contributions to the field of cancer research and therapy through his inventive spirit. With a portfolio of 10 patents, he has focused on the application of microRNAs in treating various forms of cancer, showcasing his dedication to advancing medical science.
Latest Patents
Galun's latest innovations include groundbreaking patents that enhance cancer therapy. One notable patent is for "Tumor suppressive microRNAs for cancer therapy," which presents compositions containing agents that boost the expression of endogenous tumor suppressive microRNAs. These enhancements aim to affect target cancer cells, paving the way for innovative cancer treatments. Another key patent features "miR-122* as an active micro-RNA," which provides methods for increasing the expression and stability of p53 in target cells. This patent also explores the potential of miR-122* for inducing cancer cell death, offering hope for new therapeutic strategies.
Career Highlights
Throughout his career, Eithan Galun has been associated with notable organizations, including Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work in these institutions has been pivotal in translating fundamental research into practical solutions for cancer therapy.
Collaborations
In his endeavors, Galun has collaborated with esteemed colleagues such as Hilla Giladi and Stefan Rose-John. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in driving innovation in the medical field.
Conclusion
Eithan Galun's innovative work exemplifies the profound impact of research and invention on cancer therapy. His patents reflect a commitment to enhancing therapeutic options for patients, making significant strides in the fight against cancer. With his ongoing contributions, Galun continues to inspire future generations of inventors and researchers in the field of medical science.